Psilocybin is an effective treatment against depression in largest-ever randomized trial

A drug trial with 233 patients in Europe and North America revealed promising results for psilocybin as a treatment for depression. The test was undertaken by Compass Pathways a mental health care company.

From Stat:

The Phase 2b study is the largest randomized, controlled, double-blind trial of psilocybin, the psychedelic compound in magic mushrooms.